FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Pedro
Mogollón Arroyo
Investigador en el periodo 2019-2021
Publicaciones en las que colabora con Pedro Mogollón Arroyo (6)
2021
-
Evaluación preclínica de mecanismos de resistencia a fármacos inmunomoduladores en mieloma múltiple
Evaluación preclínica de mecanismos de resistencia a fármacos inmunomoduladores en mieloma múltiple
-
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma
Cells, Vol. 10, Núm. 3
2020
-
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
Haematologica
-
Protein translation inhibition is involved in the activity of the pan-pim kinase inhibitor pim447 in combination with pomalidomide-dexamethasone in multiple myeloma
Cancers, Vol. 12, Núm. 10, pp. 1-20
2019
-
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma
Cells, Vol. 8, Núm. 11
2017
-
The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma
Haematologica, Vol. 102, Núm. 12, pp. 2113-2124